Opportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapy

被引:1
|
作者
Kustovs, Dmitrijs [1 ]
Urtane, Inga [1 ]
Sevostjanovs, Eduards [2 ]
Moreino, Eva [3 ]
Trusinskis, Karlis [3 ]
机构
[1] Riga Stradins Univ, Dept Pharmaceut Chem, LV-1007 Riga, Latvia
[2] Latvian Inst Organ Synth, Lab Phys Organ Chem, LV-1006 Riga, Latvia
[3] Riga Stradins Univ, Dept Internal Dis, LV-1007 Riga, Latvia
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 02期
关键词
amlodipine; dehydro-amlodipine; adherence; hypertension; drug monitoring; LC-MS/MS METHOD; CHROMATOGRAPHY-MASS-SPECTROMETRY; CALCIUM-CHANNEL BLOCKERS; HUMAN PLASMA APPLICATION; ADHERENCE; HYPERTENSION; BLOOD; PHARMACOKINETICS; VALIDATION; VALSARTAN;
D O I
10.3390/medicina59020340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Blood pressure measurement is essential evidence to establish that the chosen medicine and dosage are appropriate, and also indirectly indicates whether the medicine is being used at all. Therefore, current research compares adherence to the target blood pressure at home and in the hospital between different age groups, using similar combinations of the drugs prescribed by the doctor within ongoing antihypertensive therapy. Moreover, it is very important to develop a method for the determination of amlodipine and its metabolite, which would suitable for clinical applications, when the result is needed as quick as possible. Materials and Methods: This prospective study included patients aged >= 18 years who were diagnosed with hypertension. Subjects were divided into two age groups according to European Society of Cardiology (ESC) hypertension guidelines; older patients (>= 65 years) and adult patients (<65 years). Assessment of adherence rate to antihypertensive medications was performed using a measurement of systolic blood pressure and comparing this to ESC hypertension guideline data. A simple liquid chromatography-tandem mass spectrometer (LC-MS/MS) method for determination of amlodipine and dehydroamlodipine was developed and validated according to the European Medicines Agency guideline on bioanalytical method validation at the Latvian Institute of Organic Synthesis. Results: A total of 81 patients with arterial hypertension were enrolled in this study. A significant number of patients were overweight (N = 33, 40.7%) and obese (N = 36, 44.4%). To control arterial hypertension, 70 (86.4%) patients used fixed-dose combinations, where one of the components was amlodipine. Practically, 36 (44.4%) hypertensive subjects were not able to comply with target blood pressure. Nonetheless, 38 (46.9%) patients who received fixed-dose combinations were able to comply with target blood pressure. Conclusions: Adherence to ESC hypertension guideline proposed target blood pressure was relatively low among hypertensive subjects even though a significant number of patients were taking fixed-dose combinations. Therefore, optimizing prevention, recognition, and care of hypertensive young adults require intensive educational interventions. Moreover, survey data suggest that therapeutic drug monitoring using the validated simple, sensitive LC-MS/MS method is pivotal for further understanding factors influencing adherence.
引用
收藏
页数:21
相关论文
共 22 条
  • [1] Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components
    Stafylas, Panagiotis
    Kourlaba, Georgia
    Hatzikou, Magda
    Georgiopoulos, Dimitrios
    Sarafidis, Pantelis
    Maniadakis, Nikolaos
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
  • [2] Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy
    Waeber, Bernard
    Feihl, Francois
    EUROINTERVENTION, 2013, 9 : R29 - R34
  • [3] Risk of Dementia During Antihypertensive Drug Therapy in the Elderly
    Rea, Federico
    Corrao, Giovanni
    Mancia, Giuseppe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1194 - 1203
  • [4] Fixed-Drug Combination of Amlodipine, Indapamide and Perindopril: New Horizons of Antihypertensive Therapy
    Kobalava, Zh. D.
    Troitskaya, E. A.
    Ezhova, N. E.
    KARDIOLOGIYA, 2017, 57 (04) : 79 - +
  • [5] A simple test to appreciate compliance with antihypertensive drug therapy
    Wenzel, Ulrich
    Stange, Dorit
    Duesing, Rainer
    JOURNAL OF HYPERTENSION, 2012, 30 (03) : 624 - 624
  • [6] Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components
    Panagiotis Stafylas
    Georgia Kourlaba
    Magda Hatzikou
    Dimitrios Georgiopoulos
    Pantelis Sarafidis
    Nikolaos Maniadakis
    Cost Effectiveness and Resource Allocation, 13
  • [7] Compliance enhancement in drug therapy. Opportunities and limitations
    Krolop, L.
    Jaehde, U.
    INTERNIST, 2012, 53 (01): : 99 - 106
  • [8] Phase 1 Evaluation of the Bioequivalence and Drug-Drug Interaction Potential of a Novel Fixed-Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine
    Lim, Hyung Soon
    Kim, Jae Hoon
    Hong, Jang Hee
    Jung, Jin-Gyu
    Sunwoo, Jung
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (12): : 1345 - 1354
  • [9] Computational investigation of metal organic frameworks as potential drug carriers for antihypertensive amlodipine
    Liu, Jiaqi
    Yang, Zhen
    Che, Yuanyuan
    Zhang, Yaojie
    Zhang, Zhihao
    Zhao, Chun-Xia
    AICHE JOURNAL, 2022, 68 (01)
  • [10] Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: A randomized clinical trial using electronic monitoring
    Leenen, FHH
    Wilson, TW
    Bolli, P
    Larochelle, P
    Myers, M
    Handa, SP
    Boileau, G
    Tanner, J
    CANADIAN JOURNAL OF CARDIOLOGY, 1997, 13 (10) : 914 - 920